We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+1.58%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$805M
AUM Growth
+$2.82M
Cap. Flow
-$5.52M
Cap. Flow %
-0.69%
Top 10 Hldgs %
21.48%
Holding
266
New
7
Increased
69
Reduced
92
Closed
7

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$1.49M
2
JAH
JARDEN CORPORATION
JAH
+$861K
3
AGN
Allergan plc
AGN
+$842K
4
LH icon
Labcorp
LH
+$776K
5
ECL icon
Ecolab
ECL
+$712K

Sector Composition

Rank Sector Weight
1 Healthcare 18.07%
2 Industrials 14.98%
3 Miscellaneous 14.57%
4 Technology 12.91%
5 Consumer Staples 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
51
McDonald's
MCD
$179B
$4.97M 0.62%
51,054
-12,111
-19% -$1.15M
ABT icon
52
Abbott
ABT
$177B
$4.8M 0.6%
103,570
-205
-0.2% -$9.41K
DD
53
DELISTED
Du Pont De Nemours E I
DD
$4.77M 0.59%
70,335
-2,192
-3% -$156K
CVS icon
54
CVS Health
CVS
$121B
$4.75M 0.59%
46,065
+50
+0.1% +$5.06K
KMI icon
55
Kinder Morgan
KMI
$68.6B
$4.66M 0.58%
110,859
+3,668
+3% +$152K
PFE icon
56
Pfizer
PFE
$157B
$4.61M 0.57%
139,532
-210
-0.2% -$6.68K
VEA icon
57
Vanguard FTSE Developed Markets ETF
VEA
$234B
$4.6M 0.57%
115,544
-790
-0.7% -$31K
QQQ icon
58
Invesco QQQ Trust
QQQ
$473B
$4.47M 0.55%
42,313
+435
+1% +$45.7K
NVS icon
59
Novartis
NVS
$264B
$4.46M 0.55%
50,424
-53
-0.1% -$4.7K
XRAY icon
60
Dentsply Sirona
XRAY
$1.98B
$4.45M 0.55%
87,509
-1,300
-1% -$67K
MKC icon
61
McCormick & Company Non-Voting
MKC
$13.5B
$4.39M 0.55%
113,910
-400
-0.3% -$14.8K
CVX icon
62
Chevron
CVX
$425B
$4.35M 0.54%
41,450
-113
-0.3% -$12.1K
MSFT icon
63
Microsoft
MSFT
$3.68T
$4.33M 0.54%
106,527
+205
+0.2% +$8.93K
LOW icon
64
Lowe's Companies
LOW
$109B
$4.3M 0.53%
57,819
-200
-0.3% -$14.3K
ADP icon
65
Automatic Data Processing
ADP
$110B
$4.09M 0.51%
47,810
AMZN icon
66
Amazon
AMZN
$2.67T
$4.08M 0.51%
219,360
+3,240
+1% +$57K
CL icon
67
Colgate-Palmolive
CL
$69.5B
$3.99M 0.5%
57,504
-2,200
-4% -$152K
BEN icon
68
Franklin Templeton
BEN
$16.9B
$3.9M 0.48%
75,965
-215
-0.3% -$11.4K
KO icon
69
Coca-Cola
KO
$381B
$3.84M 0.48%
94,665
-350
-0.4% -$14.6K
DIS icon
70
Walt Disney
DIS
$183B
$3.83M 0.48%
36,532
+1,195
+3% +$121K
CSCO icon
71
Cisco
CSCO
$433B
$3.82M 0.47%
138,757
-525
-0.4% -$14.8K
QCOM icon
72
Qualcomm
QCOM
$200B
$3.77M 0.47%
54,440
-685
-1% -$48.3K
TGT icon
73
Target
TGT
$70.1B
$3.76M 0.47%
45,802
-325
-0.7% -$25.1K
LKQ icon
74
LKQ Corp
LKQ
$5.95B
$3.72M 0.46%
145,435
-3,100
-2% -$80.3K
MO icon
75
Altria Group
MO
$117B
$3.68M 0.46%
73,571
-500
-0.7% -$26.5K

Similar funds

Boston Family Office's Q1 2015 Portfolio in Review

As of Q1 2015, Boston Family Office held 266 positions worth $805M, up 0.35% from $803M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2015 filing shows 7 new, 69 increased, 92 reduced and 7 closed positions. Its largest new stake was Medtronic: 19,713 shares worth $1.54M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $1.98M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Miscellaneous.

  • Boston Family Office's largest Q1 2015 buy was Medtronic: 19,713 shares worth $1.54M.
  • Boston Family Office added most to Allergan plc in Q1 2015, an estimated $842K increase.
  • Boston Family Office's biggest Q1 2015 reduction was Gilead Sciences, cutting an estimated $1.33M.
  • Boston Family Office fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $1.98M.
  • Boston Family Office's ten largest holdings make up 21% of its $805M portfolio in Q1 2015.
  • Boston Family Office opened 7 new positions and closed 7 in Q1 2015.
  • Boston Family Office's portfolio value rose 0.35% quarter-over-quarter to $805M.

Based on Boston Family Office's 13F filing for Q1 2015, filed 11 May 2015.